// App-Quantinova.ai

11018 : Circulating tumor cell (CTC) EMT and stem cell biomarker expression predict overall survival (OS) in mCRC by a combined immunomagnetic qRT-PCR approach.

Researchers

Presenter

  • Yan Ning

Principal Investigators

  • Wu Zhang

  • Diana L. Hanna

  • Becky Flores

  • Siegfried Hauch

  • Afsaneh Barzi

  • Anthony B. El-Khoueiry

  • Yu Sunakawa

  • Stefan Stremitzer

  • Satoshi Matsusaka

  • Satoshi Okazaki

  • Anish Parekh

  • Rita Elie El-Khoueiry

  • Heinz-Josef Lenz

  • Angela Mendez

  • Dongyun Yang

Medical Centers

  • University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA

  • AdnaGen, Langenhagen, GermanyDepartment of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, JapanUniversity of Southern California Norris Comprehensive Cancer Center, Pasadena, CA

  • Medical University Vienna, Santa Monica, CA

  • University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA

  • University of Southern California, Los Angeles, CA

  • Alere San Diego,inc., San Diego, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal Cancer

Biomarkers

  • Aldehyde dehydrogenase 1

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Circulating tumor cells

  • Cytokeratin 20

  • Solute Carrier Family 22 Member 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved